NEW YORK (GenomeWeb) – Belgian personalized cancer firm OncoDNA said today it has been awarded a contract to conduct testing and analysis for the Breast International Group (BIG), a Brussels non-profit that funds breast cancer research.

Under the multi-year contract, OncoDNA will perform its OncoDEEP Clinical Plus test on primary and metastatic tumor and blood samples from BIG's AURORA breast cancer clinical research program, which launched on April 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.